THERASTAT, CHERRY- cherry cough drops lozenge 
HART Health

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

THERASTAT, CHERRY

Active ingredient (in each lozenge)

Menthol 7 mg

Purpose

Cough suppressant/oral anesthetic

Uses

Temporarily relieves sore throat and cough occurring with a cold

Warnings

Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor right away

Ask a doctor before use if you have

Stop use and ask a doctor if:

These could be signs of a serious condition

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222

Directions

Do not take more than directed

Adults and children 12 years of age and over:

allow one lozenge to dissolve slowly in mouth
may be repeated every 2 hours as needed or as directed by a doctor
Children under 12 years of age: ask a doctor

Other information

Inactive ingredients 

corn syrup, eucalyptus oil, FD&C red #40, natural & artificial flavors, soy lecithin, sucrose, water

TherastatCherry.jpg

THERASTAT, CHERRY 
cherry cough drops lozenge
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50332-0147
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL7 mg
Inactive Ingredients
Ingredient NameStrength
CORN SYRUP (UNII: 9G5L16BK6N)  
EUCALYPTUS OIL (UNII: 2R04ONI662)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
SUCROSE (UNII: C151H8M554)  
WATER (UNII: 059QF0KO0R)  
Product Characteristics
ColorredScoreno score
ShapeOVALSize17mm
FlavorCHERRYImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50332-0147-450 in 1 BOX01/09/2023
11 in 1 PACKET; Type 0: Not a Combination Product
2NDC:50332-0147-7125 in 1 BOX01/09/2023
21 in 1 PACKET; Type 0: Not a Combination Product
3NDC:50332-0147-8250 in 1 BOX01/09/2023
31 in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34101/09/2023
Labeler - HART Health (069560969)

Revised: 8/2023
Document Id: 520b9a82-6d31-46f8-85c0-0725655784ee
Set id: 7bb2717f-8a34-466e-9498-07e2cb54c878
Version: 1
Effective Time: 20230809
 
HART Health